Other languages Neuronetics, Inc.

Equities

STIM

US64131A1051

Market Closed - Nasdaq Other stock markets 01:30:00 27/04/2024 am IST			5-day change	1st Jan Change
3.49 ^USD	-0.85%		-8.16%	+20.34%

10/04	Neuronetics, Inc. Announces the Publication of Significant Clinical Findings in Brain Stimulation: Basic, Translational, and Clinical Research in Neuromodulation	CI
28/03	Neuronetics, Inc. Announces John K. Bakewell, Joseph H. Capper and Dr. Wilfred E. Jaeger Not Stand for Reelection to the Board	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Neuronetics, Inc. Announces the Publication of Significant Clinical Findings in Brain Stimulation: Basic, Translational, and Clinical Research in Neuromodulation	10/04
Neuronetics, Inc. Announces John K. Bakewell, Joseph H. Capper and Dr. Wilfred E. Jaeger Not Stand for Reelection to the Board	29/03
Neuronetics Gets US FDA Clearance for Treatment of Adolescents with Depression; Shares Rise	25/03
Neuronetics, Inc. Announces Clearance from the U.S. Food and Drug Administration for NeuroStar Advanced Therapy	25/03
Neuronetics, Inc. Announces 5-Year Exclusive Partnership with Transformations Care Network	07/03
Neuronetics, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	05/03
Neuronetics, Inc. Provides Earnings Guidance for the First Quarter and Full Year 2024	05/03
Neuronetics Launches Latest Evolution in Its Trakstar® Patient Data Management System	12/02
Top Premarket Gainers	25/01
Neuronetics, Inc. Revises Earnings Guidance for the Fourth Quarter and Full Year of 2023	08/01
Neuronetics Receives 510(K) Clearance for Neurosite Coil Placement Accessory	18/12
Neuronetics, Inc. Elevates Depression Treatment with Cutting-Edge Technology Advancements	13/11
Neuronetics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	07/11
Neuronetics, Inc. Provides Revenue Guidance for the Fourth Quarter and Full Year 2023	07/11
Neuronetics Draws Down Remaining $22.5 Million From SLR Capital Credit Facility	03/23/03
Neuronetics, Inc. Announces the Launch of the NeuroStar Voices Portal	12/23/12
Neuronetics, Inc. Revolutionizes Patient Communication and Provider Support Through Its Exclusive TrakStar Platform	14/23/14
Neuronetics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	08/23/08
Neuronetics, Inc. Provides Revenue Guidance for the Third Quarter of 2023	08/23/08
Neuronetics, Inc. Revises Revenue Guidance for the Year Full Year 2023	08/23/08

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Neuronetics, Inc.

Equities

STIM

US64131A1051

Other languages

Filters